Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of Transvenous Limb Perfusion With Normal Saline in Human Muscular Dystrophy

NCT00873782 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT00873782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00873782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of Transvenous Limb Perfusion With Normal Saline in Human Muscular Dystrophy
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2009
Completion date
February 28, 2014
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

becker muscular dystrophy, duchenne muscular dystrophy, limb-girdle muscular dystrophy, muscular dystrophies